[PDF][PDF] Tumor necrosis factor α as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose
ML Harrison, E Obermueller, NR Maisey… - Journal of Clinical …, 2007 - academia.edu
… Provision of study materials or patients: Nick R. Maisey, David Chao, … Li Z, Amato R,
Papandreou CN: Phase II study of thalidomide for patients with metastatic renal cell cancer (MRCC) …
Papandreou CN: Phase II study of thalidomide for patients with metastatic renal cell cancer (MRCC) …
Treatment of SW620 cells with Tomudex and oxaliplatin induces changes in 2-deoxy-D-glucose incorporation associated with modifications in glucose transport
TAD Smith, NR Maisey, JC Titley… - Journal of Nuclear …, 2000 - Soc Nuclear Med
Many studies suggest that changes in the uptake of the glucose analog FDG after therapy,
compared with pretreatment uptake, predicts tumor response to therapy. However, clinical …
compared with pretreatment uptake, predicts tumor response to therapy. However, clinical …
Lipopolysaccharide‐induced carotid body inflammation in cats: functional manifestations, histopathology and involvement of tumour necrosis factor‐α
…, S Rey, PP Cortés, KR Maisey… - Experimental …, 2008 - Wiley Online Library
In the absence of information on functional manifestations of carotid body (CB) inflammation,
we studied an experimental model in which lipopolysaccharide (LPS) administration to …
we studied an experimental model in which lipopolysaccharide (LPS) administration to …
A rare case of intravascular lymphoma diagnosed on bone marrow trephine
NR Maisey, JS Waters, D Collins, J Schofield… - Leukemia & …, 2003 - Taylor & Francis
Intravascular lymphoma (IVL) is an extremely rare form of extra-nodal non-Hodgkins lymphoma
characterised by the proliferation of neoplastic lymphocytes within the lumina of small …
characterised by the proliferation of neoplastic lymphocytes within the lumina of small …
51Cr-EDTA/99Tcm-MDP ratio: a simple non-invasive method for assessing renal osteodystrophy
…, D Taube, S Edwards, MN Maisey… - The British Journal of …, 1989 - academic.oup.com
… We would like to thank the physicians of Guy's Renal Unit R^NICK, D 1974 Erosive
arthritis of the hand and wrist in for referring their patients, the nurses of Guy's Nuclear …
arthritis of the hand and wrist in for referring their patients, the nurses of Guy's Nuclear …
Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced …
…, A Garcia, T Waddell, K Guptal, N Maisey… - JAMA …, 2021 - jamanetwork.com
Importance Older and/or frail patients are underrepresented in landmark cancer trials. Tailored
research is needed to address this evidence gap. Objective The GO2 randomized clinical …
research is needed to address this evidence gap. Objective The GO2 randomized clinical …
[HTML][HTML] Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a …
…, C Lowe, JF Seligmann, J Wadsley, N Maisey… - The lancet …, 2013 - thelancet.com
Background Therapeutic antibodies targeting EGFR have activity in advanced colorectal
cancer, but results from clinical trials are inconsistent and the population in which most benefit …
cancer, but results from clinical trials are inconsistent and the population in which most benefit …
Antitumor necrosis factor (TNF-a) antibodies in the treatment of renal cell cancer
N Maisey - Cancer investigation, 2007 - Taylor & Francis
The kinase inhibitors sorafinib and sunitinib have demonstrated significant activity in renal
cell carcinoma (RCC), and are now approved by the FDA for use in advanced disease. There …
cell carcinoma (RCC), and are now approved by the FDA for use in advanced disease. There …
[HTML][HTML] Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non …
…, L Gervais-Andre, B Russell, N Maisey… - British Journal of …, 2022 - bjsm.bmj.com
Background There is increasing evidence for the use of exercise in cancer patients and data
supporting enhanced tumour volume reduction following chemotherapy in animal models. …
supporting enhanced tumour volume reduction following chemotherapy in animal models. …
Considerations when choosing oral chemotherapy: identifying and responding to patient need
S Irshad, N Maisey - European Journal of Cancer Care, 2010 - Wiley Online Library
IRSHAD S. & MAISEY N. (2010) European Journal of Cancer Care19, 5–11 Considerations
when choosing oral chemotherapy: identifying and responding to patient need Oral …
when choosing oral chemotherapy: identifying and responding to patient need Oral …